Aura Biosciences, Inc. (AURA) Tops Q3 EPS by 4c

Aura Biosciences, Inc. (NASDAQ: AURA) reported Q3 EPS of ($0.48), $0.04 better than the analyst estimate of ($0.52).

For earnings history and earnings-related data on Aura Biosciences, Inc. (AURA) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Deutsche Bank Upgrades Wickes Group plc (WIX:LN) to Hold
• Corpay agrees to $100M FTC settlement over marketing practices